Risk for Developing Type 1 Diabetes Doubled With Paternal Link by Lori Solomon for HealthDay.com, 16 August 2024.
Individuals are less likely to have type 1 diabetes if their mother has the condition than if their father is affected, according to a study scheduled to be presented at the annual meeting of the European Association for the Study of Diabetes, being held from Sept. 9 to 13 in Madrid.
Lowri A. Allen, M.B.Ch.B., from Cardiff University in the United Kingdom, and colleagues found that almost twice as many individuals had an affected father versus mother.
Read more: Risk for Developing Type 1 Diabetes Doubled With Paternal Link
DreaMed Simplifies Diabetes Care via AI-Driven Recommendations by StartUpHealth.com.
This Israeli-born startup has developed a platform, endo.digital, which processes mountains of diabetes-related data, from new and emerging devices and sources, so physicians can focus on patient care.
For physicians, the tidal wave of diabetes health data causes endocrinologists and their staff to spend so much time combing through digital platforms and information that they experience information overload. They then can end up giving less attention to their patients, leading to clinician burden, frustration, and concern for patient wellbeing. As access to diabetes devices expands, data overload also becomes a problem for primary care physicians. These doctors aren’t diabetes specialists, so the web of new diabetes data sources is even more overwhelming. As a result, these doctors end up sending individuals back to an endocrinologist — of which there are too few — who now have a backlog of patients with data they need to wade through.
Professor Moshe Phillip, MD, Director of the Institute of Endocrinology and Diabetes at the National Center for Juvenile Diabetes at Schneider Children’s in Israel, along with Eran Atlas, a biomedical engineering student at Tel Aviv University and Revital Nimri, MD, from Schneider Children’s Institute focused on the development of an artificial pancreas system suitable for people with Type 1 diabetes. Together with their partners, Prof Thomas Danne and Prof. Tadej Battelino, their team was the first in the world to take a group of patients into a hotel, simultaneously in three different countries, give them laptops, and monitor the use of an algorithm to automate their insulin delivery while they slept. This initial study was published in the New England Journal of Medicine — the first such findings to be shared in the publication. Eventually, this solution was sold to Medtronic and is part of MiniMed 780G.
Then their vision turned to how they could take that large amount of digital data and automate it to reflect how physicians actually think: treatment, recommendations, and even a way to incorporate billing all in one place through the use of artificial intelligence. In 2015, they established DreaMed, where the website for their product, endo.digital, says, “We treat the data, you treat the person.”
DreaMed helps doctors decrease the number of process steps without having to engage with more technology or increase their data management, down from 30 steps down to 12 and what once took 25 minutes to complete could now take nine minutes less , including automating all billing.
Read more: DreaMed Simplifies Diabetes Care via AI-Driven Recommendations
FOCUS on ART: Appleton Art Works AppletonArtWork.com: Diabetes Awareness Through Art. I’ve been fascinated with Appleton’s creativity for many years … wildly inventive, such serious topics brought to life!
Appleton (Artworks) is an artist and photographer who has been creating art, images and sculptures all of his life.
After surviving a diabetic coma at the age of six, Appleton began to collect almost every insulin bottle that has gone through his system, amounting to hundreds of bottles, faded syringes and old blood strips.
Appleton wants to inspire the millions who have diabetes–to carry on and realize that you are not alone in this daily. Through his art, Appleton seeks to raise and spread awareness. By putting his message on the streets, he asks passersby to wonder what they see, what they are looking at….something over 30 million American diabetics look at everyday. battle.
Through his art, Appleton seeks to raise and spread awareness. By putting his message on the streets, he asks passersby to wonder what they see, what they are looking at….something over 30 million American diabetics look at everyday.
Read more: Appleton Artwork
The surprising science of coffee and its effect on both body and mind by Jasmin Fox-Skelly for NewScientist.com, 20 August 2024. The latest research on caffeine reveals why coffee and decaf can be so good for your health, but energy drinks can be lethal
“I only drink coffee on days ending in y,” so the saying goes. Coffee’s best-known component, caffeine, is estimated to be the most widely used psychoactive drug in the world, with billions of people consuming it every day. But unlike other addictive substances, it is largely unregulated, and nobody would flinch at the idea that you might struggle to function without it from the moment you wake up.
It only takes around 45 minutes for all the caffeine from a cup of coffee to be absorbed into your circulatory system, where it travels to the brain, easily crossing the blood-brain barrier. Here, it binds to and blocks receptors for the neurotransmitter adenosine. This chemical builds up as the day goes on and dampens nerve fiber activity to make us sleepy. “It slows us down,” says Jennifer Temple at the University at Buffalo in New York. “Caffeine competes with adenosine for access to the receptor, so it has the opposite action – it makes us feel more energetic, alert and awake.”
Caffeine’s presence in energy drinks in particular is often marketed as a way of focusing attention, improving exam performance, and enhancing athletic prowess. After people consume caffeine, they tend to report feeling happier, and there are signs that this substance could even cause a longer-term mood boost. The same relationship hasn’t been shown with decaffeinated coffee, suggesting that caffeine itself is responsible. It has been found that drinkers of caffeinated coffee have a significantly lower risk of developing Parkinson’s disease. It is also known to increase levels of the neurotransmitter dopamine in the brain.
Caffeine in energy drinks: According to The Dark Side of Energy Drinks, these products often contain other legal stimulants, such as guarana, taurine and L-carnitine. Some of these act to further increase blood pressure, heart rate and breathing rate.
Read more:
